Lipophilic statins
Lipophilic statins has been studied in 7 papers since 2017: 6 observational studies in people, 1 in animals; 3 in the past year. The newest paper, Jul 29, 2026: “Sustained High-Intensity Lipophilic Statin Use and Risk of Age-Related Macular Degeneration: A Target Trial Emulation”.
7 papers study it7 findingsUpdated
“compared with lipophilic statins (aHR, 0.76; 95% CI, 0.69-0.82).”
1 of its findings points the other way.
- 5 independent labs in 2 countries
- 1 finding against
- Funders: National Eye Institute and 3 more
- 2 of 7 findings with company ties
- Humans6
- Animals1
What did studies of Lipophilic statins find?
1Studies of Lipophilic statins measured 1 outcome; the most studied are Parkinson's disease progression (1 study).
Parkinson's disease progression
no changein humans1
1 study
Parkinson's disease progression
no changein humans1
Lipophilic statins were not clearly linked with Parkinson's disease progression in humans (Compared with statin non-users).
“Compared to statin non-users, overall statin or lipophilic statin use did not significantly influence PD clinical or imaging progression.”
HumansCompared with statin non-users18 months
Parkinson's Disease Progression and Statins: Hydrophobicity Matters
Journal of Parkinson's disease
What is Lipophilic statins linked with?
5Studies link Lipophilic statins with 5 measures, most often dementia (1 study), exudative age-related macular degeneration (1) and nonexudative age-related macular degeneration (1).
Dementia
downin humans1upin humans1OR 0.94–1.07
1 study
Dementia
downin humans1upin humans1OR 0.94–1.07
Lipophilic statins are linked with a lower risk of dementia in humans (diabetic microvascular disease subgroup, LDL-C < 50 mg/dL) (OR 0.94, CI: 0.911-0.973, p < 0.05).
“The increased risk for lipophilic statins was not seen in the diabetic microvascular disease subgroup (LDL-C < 50 mg/dL: OR 0.94, CI: 0.911-0.973, p < 0.05).”
Humansdiabetic microvascular disease subgroup, LDL-C < 50 mg/dLpredominantly males
Low LDL-C Achieved with Lipophilic Statins Is Associated with a Higher Risk of Cognitive Dysfunction
ADA Scientific Sessions 2026 abstract
Lipophilic statins are linked with a higher risk of dementia in humans (LDL-C < 50 mg/dL) (OR 1.07, 95% CI: 1.04-1.09, p < 0.05).
“lipophilic statins were associated with higher odds of dementia compared to hydrophilic statins (LDL-C < 50 mg/dl: OR 1.07, 95% CI: 1.04-1.09, p < 0.05”
HumansLDL-C < 50 mg/dLpredominantly males
Low LDL-C Achieved with Lipophilic Statins Is Associated with a Higher Risk of Cognitive Dysfunction
ADA Scientific Sessions 2026 abstract
Exudative age-related macular degeneration
downin humans1
1 study
Exudative age-related macular degeneration
downin humans1
Lipophilic statins are linked with a lower risk of exudative age-related macular degeneration in humans (progression from nonexudative AMD in adults aged ≥55 years) (sHR 0.62 (95% CI, 0.45-0.87)).
“exudative AMD developed in 66 of 1082 exposed participants (6.10%) and 85 of 1082 unexposed participants (7.86%) (sHR = 0.62, 95% CI, 0.45-0.87; P = 0.006”
Humansprogression from nonexudative AMD in adults aged ≥55 yearsretina2.1 ± 1.6 yearsn = 1,082
Ophthalmology. Retina
Nonexudative age-related macular degeneration
downin humans1
1 study
Nonexudative age-related macular degeneration
downin humans1
Lipophilic statins are linked with a lower risk of nonexudative age-related macular degeneration in humans (sustained high-intensity exposure in hypertensive adults aged ≥55 years) (sHR 0.53 (95% CI, 0.38-0.74)).
“nonexudative AMD developed in 68 of 8633 exposed participants (0.79%) and 88 of 8633 unexposed participants (1.02%) (sHR = 0.53, 95% confidence interval [CI], 0.38-0.74; P = 0.0002”
Humanssustained high-intensity exposure in hypertensive adults aged ≥55 yearsretina2.8 ± 1.8 yearsn = 8,633
Ophthalmology. Retina
Delirium
downin humans1
1 study
Delirium
downin humans1
Lipophilic statins are linked with a lower risk of delirium in humans (type 2 diabetes mellitus) (aHR 0.76, 95% CI 0.69-0.82).
“compared with lipophilic statins (aHR, 0.76; 95% CI, 0.69-0.82).”
Humanstype 2 diabetes mellituslipophilic
Statins Reduce Delirium Risk in Older Adults With Type 2 Diabetes
Journal of the American Medical Directors Association
Mortality
downin humans1HR 0.77
1 study
Mortality
downin humans1HR 0.77
Lipophilic statins are linked with a lower risk of mortality in humans (aging cancer survivors) (HR 0.77, P = 0.003).
“the group receiving lipophilic statins exhibited a notable decrease in all-cause mortality risk (adjusted HR, 0.77; P = 0.003).”
Humansaging cancer survivorsn = 2,968
Aging clinical and experimental research